All Stories

  1. In Silico Identification and Characterization of Spiro[1,2,4]triazolo[1,5-c]quinazolines as Diacylglycerol Kinase α Modulators
  2. The Application of S-Substituted Pteridine for CCl4-Induced Acute Hepatitis Treatment in Rats
  3. Application of S‐Substituted Pteridine for Acute Hepatitis Treatment in Rats
  4. Search for Potential Neuroprotectors for Correction of Cognitive and Behavioral Disorders After Ketamine Anesthesia Among 2′-R-6’H-Spiro(cycloalkyl-, heterocyclyl)[1,2,4]triazolo[1,5-<em>c</em>]Quinazolines: Fragment-Oriented Design, Molecu...
  5. In Silico Identification and Characterization of Spiro [1,2,4]triazolo[1,5-<i>c</i>]quinazolines as Diacylglycerol Kinase α Modulators
  6. Search for Potential Neuroprotectors for Correction of Cognitive and Behavioral Disorders After Ketamine Anesthesia Among 2′-R-6’H-Spiro(cycloalkyl-, heterocyclyl)[1,2, 4]triazolo[1,5-C]-Quinazolines: Fragment-Oriented Design, Molecular Docking, ADMET,...
  7. Antistaphylococcal Triazole-Based Molecular Hybrids: Design, Synthesis and Activity
  8. [1,2,4]triazino[2,3-c]quinazoline hybrids with azole and azine heterocycles: design, synthesis, antibacterial and antiradical activity
  9. [2-(3-R-1H-[1,2,4]-Triazol-5-YL)Phenyl]Amines: Design, Synthesis and Assessment of Their Anti-Staphylococcal Potential
  10. Evaluation of Fifteen 5,6-Dihydrotetrazolo[1,5-c]quinazolines Against Nakaseomyces glabrata: Integrating In Vitro Studies, Molecular Docking, QSAR, and In Silico Toxicity Assessments
  11. Bioisosteric Replacement in the Search for Biologically Active Compounds: Design, Synthesis and Anti-Inflammatory Activity of Novel [1,2,4]triazino[2,3-c]quinazolines
  12. Combating <i>Candida glabrata</i>: Screening 5,6-Dihydrotetrazolo[1,5-<i>c</i>]Quinazolines through <i>In Vitro</i> Studies, Molecular Docking, QSAR and Toxicity Assessments
  13. Bioisosteric Replacement in the Search for Biologically Active Compounds: Design, Synthesis and Anti-Inflammatory Activity of Novel [1,2, 4]triazino[2,3-C]quinazolines
  14. Influence of substituted quinones on the excretory function of the rat kidney and evaluation of the prospects of their use as potential diuretics
  15. МЕТОДИ СИНТЕЗУ ХІНАЗОЛІНІВ ТА ЇХ КОНДЕНСОВАНИХ ПОХІДНИХ – ПОТЕНЦІЙНИХ ПРОТИЗАПАЛЬНИХ АГЕНТІВ (ОГЛЯД)
  16. ПОШУК НОВИХ ІНГІБІТОРІВ ТИРОЗИНКІНАЗИ СЕРЕД 2-(3-R-1H-1,2,4-ТРИАЗОЛ-5-ІЛ)АНІЛІНІВ ЯК ПОТЕНЦІЙНИХ ПРОТИПУХЛИННИХ АГЕНТІВ З ВИКОРИСТАННЯМ МОЛЕКУЛЯРНОГО ДОКІНГУ
  17. N-arylsulfonyl-2-aroylamino-1,4-quinone imines and their hydrogenated analogues: prediction of toxicity and prospects for use as diuretics
  18. 5,6‐Dihydrotetrazolo[1,5‐c]quinazolines: Toxicity prediction, synthesis, antimicrobial activity, molecular docking, and perspectives
  19. Evaluation of the toxicity and hepatoprotective properties of new s-substituted pteridins
  20. Tacrolimus and Azole Derivatives of Agricultural and Human Health Importance: Prediction of ADME Properties
  21. Combined Application of Tacrolimus with Cyproconazole, Hymexazol and Novel {2-(3-R-1H-1,2,4-triazol-5-yl)phenyl}amines as Antifungals: In Vitro Growth Inhibition and In Silico Molecular Docking Analysis to Fungal Chitin Deacetylase
  22. Design and search for prospective diuretics (CA II Inhibitors) among aroylhydrazones of esters quinone oxime using in silico and in vivo methodology
  23. In silico and in vivo screening of triamterene synthetic analogues as promising diuretics
  24. Тhio‐containing pteridines: Synthesis, modification, and biological activity
  25. ПОКРОКОВА МЕТОДИКА ВИЗНАЧЕННЯ МІНІМАЛЬНОЇ ІНГІБУЮЧОЇ КОНЦЕНТРАЦІЇ ГІДРОФОБНОЇ БІОЛОГІЧНО-АКТИВНОЇ СПОЛУКИ МЕТОДОМ РОЗВЕДЕННЯ З БУЛЬЙОНОМ
  26. Directed search for diuretics among 6-substituted pteridine-2,4,7(1H,3H,8H)-triones
  27. MOLECULAR DOCKING OF 5-PHENYL-5,6-DIHYDROTETRAZOLO- [1,5-c]QUINAZOLINES TO PENICILLIN-BINDING PROTEIN 2X (PBP 2X) AND PRELIMINARY RESULTS OF ANTIFUNGAL ACTIVITY
  28. ADME PROPERTIES PREDICTION OF 5-PHENYL-5,6-DIHYDROTETRAZOLO[1,5-c] QUINAZOLINES
  29. MOLECULAR DOCKING OF 5-PHENYL-5,6-DIHYDROTETRAZOLO-[1,5-c]QUINAZOLINES TO RIBOSOMAL 50S PROTEIN L2P (2QEX)
  30. Concepts for New Rapid Simple HPLC Method for Quantification of Fosfomycin Trometamol in Pharmaceutical Dosage Forms with Direct UV Detection
  31. Substituted acyl thioureas and acyl thiosemicarbazides: synthesis and biological activity (minireview)
  32. Heterocyclizations based on N-(R-hydrazine-1-carbonothioyl)cycloalkancarboxamides: functionalized azoles and their antimicrobial activity
  33. Carboxyl-containing quinazolines and related heterocycles as carriers of anti-inflammatory activity
  34. CИНТЕЗ ФІЗИКО-ХІМІЧНІ ВЛАСТИВОСТІ, АНТИМІКРОБНА ТА АНТИРАДИКАЛЬНА АКТИВНІСТЬ ЗАМІЩЕНИХ БЕНЗО[4,5]ІМІДАЗО[1,2-с]ХІНАЗОЛІН-6(5H)-ОНІВ (-ТИОНІВ)
  35. MOLECULAR DOCKING OF [1,2,4]TRIAZOLO [1,5-c]QUINAZOLINES TO SARS-CoV-2 NON-STRUCTURAL PROTEIN 3 MACRODOMAIN (6YWM)
  36. Chiral Monolithic Silica-Based HPLC Columns for Enantiomeric Separation and Determination: Functionalization of Chiral Selector and Recognition of Selector-Selectand Interaction
  37. ANTI-TUMOR POTENTIAL OF SUBSTITUTED 6-OXO(THIOXO)-6,7- DIHYDRO-2Н-[1,2,4]TRIAZINO[2,3-С]QUINAZOLIN-2-ONES
  38. Conformational polymorphs of 3-cyclopropyl-5-(3-methyl-[1,2,4]triazolo[4,3-a]pyridin-7-yl)-1,2,4-oxadiazole
  39. 2-Сycloalkyl-(hetaryl-)-[1,2,4]triazol[1,5-с]quinazolines: synthesis, physical and chemical properties and antibacterial activity
  40. Synthesis, antimicrobial, and mitotic toxicity evaluation of new 6‐substituted 2‐(benzo[4,5]imidazo[1,2‐ c ]quinazolin‐5( 6 H )‐yl)acetic...
  41. A Novel Series of [1,2,4]Triazolo[4,3-a]Pyridine Sulfonamides as Potential Antimalarial Agents: In Silico Studies, Synthesis and In Vitro Evaluation
  42. Concomitant polymorphic forms of 3-cyclopropyl-5-(2-hydrazinylpyridin-3-yl)-1,2,4-oxadiazole
  43. Novel N ‐Cycloalkylcarbonyl‐ N ′‐arylthioureas: Synthesis, Design, Antifungal Activity and Gene Toxicity
  44. 2-[(3-Aminoalkyl-(alkaryl-,aryl-))-1H-1,2,4-triazol-5-yl]anilines: synthesis and anticonvulsant activity
  45. Synthesis and structure of pyrido[1,2-a]quinazoline condensed derivatives
  46. Substituted 3-R-2,8-Dioxo-7,8-dihydro-2H-pyrrolo[1,2-a][1,2,4]triazino-[2,3-c]quinazoline-5a(6H)carboxylic Acids and Their Salts – a Promising Class of Anti-inflammatory Agents
  47. Directed Search of Anti-inflammatory Agents Among (3HQuinazoline- 4-ylidene)hydrazides of N-protected Amino acids and their Heterocyclization Products
  48. ЗАМІЩЕНІ 3-R-7,8-ДИГІДРО-2Н-ПІРОЛО[1,2-а][1,2,4]ТРИАЗИНО[2,3-с]ХІНАЗОЛІН-5а(6Н)-АЛКІЛКАРБОНОВІ КИСЛОТИ – ПЕРСПЕКТИВНИЙ КЛАС МАЛОТОКСИЧНИХ ПРОТИЗАПАЛЬНИХ АГЕНТІВ
  49. Synthesis and mode of action studies of novel {2‐(3‐R‐1H‐1,2,4‐triazol‐5‐yl)phenyl}amines to combat pathogenic fungi
  50. Amides of substituted 3-(pteridin-6-yl)propanoic acids: synthesis, spectral characteristics, and cytotoxic activity
  51. Synthesis of 7-arylimidazo[1,2-a]pyrazin-8(7H)-one derivatives
  52. Synthesis, Modification, and Anticonvulsant Activity of 3′‐R1‐Spiro[indoline‐3,6′‐[1,2,4]triazino[2,3‐c]quinazolin]‐2,2′(7′H)‐diones Derivatives
  53. Directed Search of Biologically Active Compounds among Hydrogenated Isoindolylalkyl(alkylaryl-,aryl-)carboxylic Acids with Quinazoline Fragment that Modify the Carbohydrate Metabolism: Design, Synthesis and Modification
  54. Novel acyl thiourea derivatives: Synthesis, antifungal activity, gene toxicity, drug-like and molecular docking screening
  55. [1,2,4]Triazino[2,3-с]quinazolines 3*. Structure and anticancer activity of products obtained from reaction of 3-(2-aminophenyl)-6-R-1,2,4-triazin-5(2H)-ones with aryl iso(thio)cyanates
  56. 2-([1,2,4]triazolo[1,5-c]quinazoline-2-yl-)alkyl-(alkaryl-,aryl-)-amines and their derivatives. Message 2. The synthesis of (3Н-quinazoline-4-ylidene)hydrazides N-protected aminoacids, using a variety of amine-protecting approaches. Physical-chemical prop
  57. Trіazolo[1,5-c]quіnazolіnes Synthesis, antimicrobial and antifungal activity [quinazolin-4(3H)-ylidene]hydrazides of carboxylic acids (Message 1)
  58. Synthesis, Tautomerism, and Antiradical Activity of Novel Pteridinetrione Derivatives
  59. Design, Synthesis and Anti-inflammatory Activity of Derivatives 10-R-3-Aryl-6,7-dihydro-2H-[1,2,4] triazino[2,3-c]quinazolin-2-ones of Spiro-fused Cyclic Frameworks
  60. Synthesis and Hypolipidemic Activity of New 6,6-Disubstituted 3-R-6,7-Dihydro-2H -[1,2,4]triazino[2,3-c ]quinazolin-2-Ones
  61. [1,2,4]Triazino[2,3-с]quinazolines 2*. Synthesis, structure, and anticonvulsant activity of new 3′-R1-spiro[(aza/oxa/thia)cycloalkyl-1(3, 4),6′-[1,2,4]triazino[2,3-c]quinazolin]-2′(7′H)-ones
  62. [1,2,4]Triazino[2,3-с]quinazolines 1. Methods for the preparation and spectral characteristics of substituted 3-R1-6-R3-6,7-dihydro-2H-[1,2,4]triazino[2,3-с]quinazolin-2-ones
  63. 3'-R-Spiro[cycloalkyl-1(2), (hetaryl-3(4), 6'-[1,2,4]triazino[2,3-c]quinazoline]-2'(7'H)-2-оnes as a perspective class of compounds with actoprotective activity
  64. 2-(Azolyl)anilines: methods of synthesis, cyclocondensations, and biological properties
  65. Preparation and biological properties of 2-thio-containing pyrimidines and their condensed analogs
  66. Dimethyl Acetylenedicarboxylate in Reactions with Substituted 3-(2-aminophenyl)-6-R1 -1,2,4-triazin-5-(2H )-ones: Structure and Properties of the Products
  67. Origin of Substituent Effect on Tautomeric Behavior of 1,2,4-Triazole Derivatives: Combined Spectroscopic and Theoretical Study
  68. Potential of N-aryl(benzyl,heteryl)-2-(tetrazolo[1,5-c]quinazolin-5-ylthio)acetamides as anticancer and antimicrobial agents
  69. 2-([1,2,4]triazolo[1,5-c]quinazolin-2-yl-)alkyl-(alkaryl-, aryl-)-amines and their derivatives. (3Н-quinazolin-4-yliden)hydrazides (1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)alkyl-(alkaryl-, aryl-)carboxylic acids: features of synthesis, modification and ant
  70. Synthesis of 6-N-R-Tetrazolo[1,5-c]quinazolin-5(6H)-ones and Their Anticancer Activity
  71. Synthesis and Characterization of Novel N‐(Phenyl, Benzyl, Hetaryl)‐2‐([1,2,4]Triazolo[1,5‐c]Quinazolin‐2‐ylthio)Acetamides by Spectral Data, Antimicrobial Activity, Molecular Docking and QSAR Studies
  72. Synthesis, Anticancer, and QSAR Studies of 2-Alkyl(aryl,hetaryl)quinazolin-4(3H)-thione's and [1,2,4]Triazolo[1,5-c]quinazoline-2-thione's Thioderivatives
  73. Dimroth rearrangement in the synthesis of substituted cyclopentaand cyclohexa[4,5]thieno[2',3':4,5]pyrimido[1,6-b][1,2,4]triazines
  74. Benzo[e][1,2,4]triazino[2,3-c][1,2,3]triazin-2-ones electro-deficient heterocyclic compounds with promising anticancer activity
  75. Investigation of actoprotective activity in a range of 6-N-R-tetrazolo[1,5-c]quinazolin-5(6H)-ones
  76. Spectrophotometric determination of original active pharmaceutical ingredient Quinabut and tablets based on it
  77. 1-R-2-([1,2,4]Triazolo[1,5-c]quinazoline-2-ylthio)etanon(ol)s: Synthesis, Bioluminescence Inhibition, Molecular Docking Studies, Antibacterial and Antifungal Activities
  78. Synthesis and hydrolytic cleavage of tetrazolo[1,5-c]quinazolines
  79. Search for Compounds with Hypoglycemic Activity in the Series of 1-(2-(1H-Tetrazol-5-yl)-R1-Phenyl)-3-R2-phenyl(ethyl)ureas and R1-Tetrazolo[1,5-c]quinazolin-5(6H)-ones
  80. Novel approach for the synthesis of N-unsubstituted 2,3,5,6-tetrahydro-4H-2,6-methano-1,3-benzoxazocine-4-thiones
  81. Interaction of 3-(2-Aminophenyl)-6-R1-1,2,4-triazin-5-ones with Acylating Reagents: An Efficient Method for Preparation of 6-Substituted 3-R1-2H-[1,2,4]triazino[2,3-c]quinazolin-2-ones
  82. 2-Alkyl(aryl)-quinazolin-4(3H)-thiones, 2-R-(quinazolin-4(3H)-ylthio)carboxylic acids and amides: synthesis, molecular docking, antimicrobial and anticancer properties
  83. 2‐Heteroaryl‐[1,2,4]triazolo[1,5‐c]quinazoline‐5(6 H)‐thiones and Their S‐Substituted Derivatives: Synthesis, Spectroscopic Data, and Biological Activity
  84. Formation of 1-methyl[1,2,4]triazolo[4,3-a] quinazolin-5(4H)-ones by reaction of 2-hydrazinoquinazolin-4(3H)-ones with acetylacetone
  85. Таутомерія 4-гідразинохіназолінів, коливальні спектри та комп'ютерне моделювання
  86. Hydrazinolysis of 3- R -[1,2,4]Triazino[2,3-c]quinazolin-2-ones. Synthetic and Theoretical Aspects
  87. Reaction of 4-chloroquinazoline with arenesulfonothioic acid salts
  88. Design and Evaluation of Novel Antimicrobial and Anticancer Agents Among Tetrazolo[1,5-c]quinazoline-5-thione S-Derivatives
  89. Synthesis and Anticancer Activity of 2-(Alkyl-, Alkaryl-, Aryl-, Hetaryl-)[1,2,4]triazolo[1,5-c]quinazolines
  90. Novel N-aryl(alkaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides: synthesis, cytotoxicity, anticancer activity, COMPARE analysis and docking
  91. Substituted 2-[(2-Oxo-2H-[1,2,4]triazino[2,3-c]quinazolin-6-yl)thio]acetamides with Thiazole and Thiadiazole Fragments: Synthesis, Physicochemical Properties, Cytotoxicity, and Anticancer Activity
  92. Synthesis of New 6-{[ω-(Dialkylamino(heterocyclyl)alkyl]thio}-3-R-2H-[1,2,4]triazino[2,3-c]quinazoline-2-ones and Evaluation of their Anticancer and Antimicrobial Activities
  93. Synthesis and biological activity of novel N-cycloalkyl-(cycloalkylaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides
  94. Synthesis, Cytotoxicity by Bioluminescence Inhibition, Antibacterial and Antifungal Activity of ([1,2,4]Triazolo[1,5-c]quinazolin-2-ylthio)carboxylic Acid Amides
  95. Synthesis of spiro-fused (C5)-pyrazolino-(C6)-triazinones, a new heterocyclic system
  96. Synthesis of New 2-Thio-[1,2,4]triazolo[1,5-c]quinazoline Derivatives and Its Antimicrobial Activity
  97. Synthesis of 5-Hydroxymethyl-8-methyl-3-(3-aryl-[1,2,4]oxadiazol-5-yl)-2H-pyrano[2,3-c]pyridin-2-ones and Their Esters
  98. 5-(3,4-Dimethylphenylsulfonyl)-8-methoxy-2-methyl-2,3,5,6-tetrahydro-4H-2,6-methano-1,3-benzoxazocin-4-one
  99. Novel Method for the Synthesis of [1,2,4]Triazino[4,3‐c]quinazoline System
  100. An Efficient and Convenient Synthesis of 2-Thio[1,2,4]triazolo[1,5-c]quinazoline and its Derivatives
  101. SYNTHESIS OF NEW 3-SUBSTITUTED DERIVATIVES OF 7-AZACOUMARINES